ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 220 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $240,000 | -44.3% | 5,789 | -19.9% | 0.15% | -45.0% |
| Q2 2022 | $431,000 | +46.6% | 7,231 | +78.8% | 0.27% | +83.0% |
| Q1 2022 | $294,000 | -25.2% | 4,044 | -13.5% | 0.15% | 0.0% |
| Q4 2021 | $393,000 | -6.9% | 4,677 | 0.0% | 0.15% | -10.9% |
| Q3 2021 | $422,000 | +17.2% | 4,677 | +23.8% | 0.16% | +19.6% |
| Q2 2021 | $360,000 | +7.1% | 3,777 | +27.9% | 0.14% | +0.7% |
| Q1 2021 | $336,000 | – | 2,952 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 38,100 | $2,928,000 | 1.67% |
| Opaleye Management Inc. | 80,000 | $6,149,000 | 1.59% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 410,000 | $31,517,000 | 1.06% |
| Opus Point Partners Management, LLC | 6,311 | $485,000 | 1.05% |
| SECTOR GAMMA AS | 68,015 | $5,228,000 | 0.87% |
| Capital Impact Advisors, LLC | 27,074 | $2,061,000 | 0.76% |
| FORTALEZA ASSET MANAGEMENT INC/ | 1,130 | $87,000 | 0.71% |
| CAPITAL INTERNATIONAL LTD /CA/ | 46,957 | $3,610,000 | 0.63% |
| Virtus ETF Advisers LLC | 8,794 | $676,000 | 0.60% |
| Rock Springs Capital Management LP | 200,000 | $15,374,000 | 0.59% |